Research location

Tunis

Tunisia

Published trials69

Site observations116

Linked trials published69

Page1 / 2

Research activity in Tunis

Tunisia

CureCurrent currently publishes aggregate city-level research activity for this location: 69 trials and 116 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Tunis

69 linked trials · page 1 of 2

Tunisian Lung Cancer StudyNCT06934499 · 2025-05-02 · 1 site observation

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerNCT05894239 · 2023-09-08 · 1 site observation

VIrtual Care To Improve Outcomes and RecoverY From Heart Failure HospitalizationNCT05724433 · 2023-01-23 · 1 site observation

The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure PatientsNCT04405583 · 2020-10-28 · 2 site observations

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate CancerNCT03819101 · 2019-06-06 · 1 site observation

Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 DiabetesNCT07467967 · 2026-07-15 · 1 site observation

NOT_YET_RECRUITING

Impact of Concept Mapping in Case-Based Learning Among Medical StudentsNCT07643116 · 2026-02-01 · 1 site observation

Diastolic Dysfunction 2025NCT07190846 · 2025-03-01 · 1 site observation

Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory ConsequencesNCT06826547 · 2025-02-15 · 1 site observation

ACTIVE_NOT_RECRUITING

Transcranial Doppler in Preeclampsia and Its Complications.NCT07646561 · 2025-01-01 · 1 site observation

A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)NCT06687369 · 2024-12-30 · 1 site observation

ACTIVE_NOT_RECRUITING

Interval Training and Cardio-metabolic Health in Overweight/Obese GirlsNCT06538714 · 2024-05-20 · 2 site observations

Preoperative Prediction of Difficult Laryngoscopy in Diabetic Patients: Importance of the Palm Print TestNCT06676865 · 2023-12-01 · 1 site observation

BH4 Blood Levels Variations in Pre Eclamptic WomenNCT05847361 · 2023-03-15 · 1 site observation

Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung CancerNCT07475637 · 2023-03-01 · 1 site observation

Prevalence of Chronic Kidney Disease in Tunisian DiabeticsNCT05577650 · 2023-01-09 · 1 site observation

0.9% Saline Versus Balanced Solutions in Severe Diabetic KetoacidosisNCT05808972 · 2022-11-01 · 1 site observation

Conventional Palpation Versus Ultrasound Assisted Spinal Anesthesia in ObstetricsNCT05846100 · 2022-11-01 · 1 site observation

Role of Depression in Blood Pressure Control. StudyNCT05516173 · 2022-08-15 · 1 site observation

Epidemiologic Register on Diabetes and COVID-19 in TunisiaNCT05603130 · 2022-03-23 · 1 site observation

Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic MenNCT05806723 · 2021-03-01 · 1 site observation

Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic DiseasesNCT04530461 · 2020-06-01 · 1 site observation

Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)NCT03961204 · 2019-08-15 · 1 site observation

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple SclerosisNCT04035005 · 2019-08-12 · 1 site observation

ACTIVE_NOT_RECRUITING

National Tunisian Registry of HypertensionNCT04013503 · 2019-04-15 · 1 site observation

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric ParticipantsNCT03870763 · 2019-03-19 · 1 site observation

Postoperative Analgesia in Breast Cancer Surgery: Safety and Efficiency of Ultrasound Guided Erector Spinae Plane BlockNCT03769428 · 2018-12-17 · 1 site observation

Biologic National RegistryNCT03793660 · 2018-05-23 · 3 site observations

Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure TherapiesNCT03412201 · 2018-05-11 · 4 site observations

Biomarkers and Preeclampsia OutcomesNCT03801447 · 2018-04-01 · 1 site observation

Paravertebral Block and Reduction in Opioid Consumption After MastectomyNCT07817797 · 2018-01-01 · 1 site observation

Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to FulvestrantNCT03447132 · 2017-12-20 · 1 site observation

A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken MethotrexateNCT02706873 · 2016-02-23 · 2 site observations

Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian PopulationNCT03799185 · 2016-01-04 · 1 site observation

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World SettingsNCT02322762 · 2014-12-30 · 1 site observation

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).NCT02222493 · 2014-08-26 · 1 site observation

Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 3 site observations

A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast CancerNCT01964391 · 2014-02-21 · 1 site observation

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute ExperienceNCT03240510 · 2014-01-01 · 1 site observation

Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During RamadanNCT01758380 · 2013-01-01 · 2 site observations

Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes PatientsNCT01589653 · 2012-05-26 · 2 site observations

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsNCT01459809 · 2012-02-01 · 4 site observations

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple SclerosisNCT01247324 · 2011-08-31 · 1 site observation

Africa and Middle East Cardiovascular Epidemiological StudyNCT01243138 · 2011-07-01 · 1 site observation

Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerNCT01308580 · 2011-04-01 · 1 site observation

An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local EnvironmentNCT01254331 · 2011-02-01 · 4 site observations

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaNCT01252355 · 2011-01-01 · 1 site observation

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation

baSal BoluS Therapy in patIenTs With TypE 1 Diabetes MellitusNCT01204593 · 2010-11-01 · 3 site observations

Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)NCT01207648 · 2010-07-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.